MarketPeel
Insider Trading Intelligence
CH

Craig C. Hopkinson

ALKS
EVP R&D, CHIEF MEDICAL OFFICER · ALKERMES PLC. · CIK 0001730048
FILING MIX · LIFETIME42%/58%
BUYS
81
SELLS
111
TOTAL VALUE
$41.60M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
1,356
AVG SELL PX
$31.94
TRADE KIND
SHOWING 192 / 192
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
25 backtested trades · 8 horizons · 39 pending
Forward-return performance of every backtestable P/S trade by Craig C. Hopkinson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d25+64.00%+0.48%+0.55%-0.07%-1.21%
14d25+68.00%-0.12%-0.50%+0.39%-1.40%
30d25+48.00%+1.87%-0.55%+1.40%+1.00%
60d25+52.00%+3.43%-1.78%+4.51%+2.44%
90d25(1 pending)+37.50%+8.61%-0.66%+7.92%+4.70%
180d25(6 pending)+31.58%+7.51%+2.69%+0.93%+1.57%
1y25(11 pending)+50.00%+5.52%+9.30%-3.78%-11.19%
2y25(21 pending)+0.00%+31.34%+12.53%+18.81%+15.30%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ALKS · 1,356 shares · as of Jul 1, 2026
065,699131,398197,097262,796202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 81 buys / 111 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,0001,356Jul 1, 2026Jul 1, 2026View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
8,300$51.46$427.1K74,089Jul 1, 2026Jul 1, 2026View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
700$52.13$36.5K73,389Jul 1, 2026Jul 1, 2026View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
5,000$19.34$96.7K82,389Jul 1, 2026Jul 1, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,0006,356Jun 1, 2026Jun 1, 2026View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
5,000$19.34$96.7K86,389Jun 1, 2026Jun 1, 2026View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
9,000$41.67$375.0K77,389Jun 1, 2026Jun 1, 2026View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
9,000$33.40$300.6K81,389May 1, 2026May 1, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,00011,356May 1, 2026May 1, 2026View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
5,000$19.34$96.7K90,389May 1, 2026May 1, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,00016,356Apr 1, 2026Apr 1, 2026View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
9,000$35.51$319.6K85,389Apr 1, 2026Apr 1, 2026View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
5,000$19.34$96.7K94,389Apr 1, 2026Apr 1, 2026View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
9,000$29.72$267.5K89,389Mar 2, 2026Mar 4, 2026View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
83,03783,037Mar 2, 2026Mar 4, 2026View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
38,56838,568Mar 2, 2026Mar 4, 2026View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
5,000$19.34$96.7K98,389Mar 2, 2026Mar 4, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,00021,356Mar 2, 2026Mar 4, 2026View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
6,86696,438Feb 26, 2026Feb 27, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,049$30.73$93.7K93,389Feb 26, 2026Feb 27, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
6,86613,732Feb 26, 2026Feb 27, 2026View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
7,68992,986Feb 23, 2026Feb 25, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,414$32.19$109.9K89,572Feb 23, 2026Feb 25, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
7,6897,690Feb 23, 2026Feb 25, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
7,67323,019Feb 19, 2026Feb 20, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,407$32.00$109.0K85,297Feb 19, 2026Feb 20, 2026View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
7,67388,704Feb 19, 2026Feb 20, 2026View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
8,89784,535Feb 18, 2026Feb 20, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
8,8970Feb 18, 2026Feb 20, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,504$32.02$112.2K81,031Feb 18, 2026Feb 20, 2026View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
25,35283,092Feb 5, 2026Feb 6, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
7,454$33.55$250.1K75,638Feb 5, 2026Feb 6, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,00026,356Feb 2, 2026Feb 2, 2026View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
5,000$19.34$96.7K66,740Feb 2, 2026Feb 2, 2026View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
4,000$33.54$134.2K57,740Feb 2, 2026Feb 2, 2026View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
5,000$34.24$171.2K61,740Feb 2, 2026Feb 2, 2026View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
5,000$19.34$96.7K66,740Jan 8, 2026Jan 8, 2026View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
5,000$30.00$150.0K61,740Jan 8, 2026Jan 8, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,00031,356Jan 8, 2026Jan 8, 2026View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
4,000$28.00$112.0K61,740Jan 2, 2026Jan 2, 2026View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,74836,356Dec 3, 2025Dec 5, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
3,748$19.34$72.5K69,488Dec 3, 2025Dec 5, 2025View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
3,748$30.00$112.4K65,740Dec 3, 2025Dec 5, 2025View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
4,000$29.30$117.2K65,740Dec 1, 2025Dec 1, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,00040,104Nov 3, 2025Nov 3, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
5,000$19.34$96.7K78,740Nov 3, 2025Nov 3, 2025View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
9,000$30.38$273.4K69,740Nov 3, 2025Nov 3, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,00045,104Oct 15, 2025Oct 15, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
5,000$19.34$96.7K82,740Oct 15, 2025Oct 15, 2025View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
9,000$31.53$283.8K73,740Oct 15, 2025Oct 15, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
6,86620,598Feb 26, 2025Feb 28, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,049$34.80$106.1K77,740Feb 26, 2025Feb 28, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
6,86680,789Feb 26, 2025Feb 28, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
7,68977,337Feb 23, 2025Feb 25, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
7,68915,379Feb 23, 2025Feb 25, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,414$35.32$120.6K73,923Feb 23, 2025Feb 25, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
12,2790Feb 22, 2025Feb 25, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
12,27975,100Feb 22, 2025Feb 25, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,452$35.32$192.6K69,648Feb 22, 2025Feb 25, 2025View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
63,99163,991Feb 19, 2025Feb 20, 2025View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
30,69230,692Feb 19, 2025Feb 20, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
8,89666,771Feb 18, 2025Feb 20, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,950$35.90$141.8K62,821Feb 18, 2025Feb 20, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
8,8968,897Feb 18, 2025Feb 20, 2025View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
35,586$34.02$1.21M166,708Feb 13, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
108,8330Feb 13, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
108,833$36.02$3.92M57,875Feb 13, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
108,833$31.93$3.48M166,708Feb 13, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
35,586$24.59$875.1K202,294Feb 13, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
35,58671,172Feb 13, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
111,630$19.34$2.16M262,796Feb 12, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
111,63050,104Feb 12, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
171,813$32.69$5.62M90,983Feb 12, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
87,5660Feb 12, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
87,566$20.03$1.75M151,166Feb 12, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
33,108$33.27$1.10M57,875Feb 12, 2025Feb 14, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
15,083$31.39$473.5K63,600Feb 6, 2025Feb 7, 2025View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
34,39378,683Feb 6, 2025Feb 7, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
23,542$24.59$578.9K126,863Jan 30, 2025Jan 31, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
18,345$26.82$492.0K145,208Jan 30, 2025Jan 31, 2025View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
100,918$32.05$3.23M44,290Jan 30, 2025Jan 31, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
29,156$20.03$584.0K76,732Jan 30, 2025Jan 31, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
18,34592,271Jan 30, 2025Jan 31, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
29,15687,566Jan 30, 2025Jan 31, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
26,589161,734Jan 30, 2025Jan 31, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
23,542106,758Jan 30, 2025Jan 31, 2025View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
26,589$19.34$514.2K103,321Jan 30, 2025Jan 31, 2025View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
12,044130,300Dec 9, 2024Dec 9, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
12,090188,323Dec 9, 2024Dec 9, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
12,090$19.34$233.8K84,272Dec 9, 2024Dec 9, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
12,411110,616Dec 9, 2024Dec 9, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
12,044$24.59$296.2K96,316Dec 9, 2024Dec 9, 2024View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
61,151$32.07$1.96M47,576Dec 9, 2024Dec 9, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
12,452$20.03$249.4K72,182Dec 9, 2024Dec 9, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
12,452116,722Dec 9, 2024Dec 9, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
12,411$26.82$332.9K108,727Dec 9, 2024Dec 9, 2024View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
9,221$31.50$290.5K59,730Dec 5, 2024Dec 5, 2024View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
14,349$30.77$441.6K68,951Dec 4, 2024Dec 4, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
43,058129,174Nov 11, 2024Nov 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
43,058$20.03$862.5K142,296Nov 11, 2024Nov 12, 2024View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
58,996$30.08$1.77M83,300Nov 11, 2024Nov 12, 2024View →
ALKS
ALKERMES PLC.
SALE10b5-1
10b5-1 plan
10,471$29.53$309.2K99,238Nov 6, 2024Nov 6, 2024View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
111,186111,186Feb 26, 2024Feb 27, 2024View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
27,46427,464Feb 26, 2024Feb 27, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,414$29.57$101.0K109,709Feb 23, 2024Feb 27, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
7,68923,068Feb 23, 2024Feb 27, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
7,689113,123Feb 23, 2024Feb 27, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,452$28.91$157.6K105,434Feb 22, 2024Feb 23, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
12,278110,886Feb 22, 2024Feb 23, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
12,27812,279Feb 22, 2024Feb 23, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
10,297103,180Feb 20, 2024Feb 21, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
10,2970Feb 20, 2024Feb 21, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
4,572$30.39$138.9K98,608Feb 20, 2024Feb 21, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
8,89717,793Feb 18, 2024Feb 21, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
8,89796,834Feb 18, 2024Feb 21, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,951$32.18$127.1K92,883Feb 18, 2024Feb 21, 2024View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
15,280$26.77$409.0K87,937Feb 8, 2024Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
46,658103,217Feb 8, 2024Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
60330,757Nov 17, 2023Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
2,133$31.93$68.1K108,833Nov 17, 2023Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
1,089$65.94$71.8K55,589Nov 17, 2023Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
2,412$26.82$64.7K123,027Nov 17, 2023Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
3,929$19.34$76.0K200,413Nov 17, 2023Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
52326,690Nov 17, 2023Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
20110,297Nov 17, 2023Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
3,376$20.03$67.6K172,232Nov 17, 2023Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
2,790$24.59$68.6K142,344Nov 17, 2023Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
1,599$58.40$93.4K81,599Nov 17, 2023Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
48124,557Nov 17, 2023Feb 12, 2024View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
30,15430,154Feb 23, 2023Feb 24, 2023View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
120,615120,615Feb 23, 2023Feb 24, 2023View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,345$27.77$148.4K56,559Feb 22, 2023Feb 24, 2023View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
12,03861,904Feb 22, 2023Feb 24, 2023View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
12,03824,076Feb 22, 2023Feb 24, 2023View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
6,87552,919Feb 21, 2023Feb 22, 2023View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
6,8750Feb 21, 2023Feb 22, 2023View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,053$27.77$84.8K49,866Feb 21, 2023Feb 22, 2023View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,780$28.07$106.1K30,375Feb 20, 2023Feb 22, 2023View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
6,526$28.07$183.2K46,044Feb 20, 2023Feb 22, 2023View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
10,09510,096Feb 20, 2023Feb 22, 2023View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
10,09534,155Feb 20, 2023Feb 22, 2023View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
22,19552,570Feb 20, 2023Feb 22, 2023View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
8,72226,716Feb 18, 2023Feb 22, 2023View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
8,72226,167Feb 18, 2023Feb 22, 2023View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
2,656$28.07$74.6K24,060Feb 18, 2023Feb 22, 2023View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
11,983$24.76$296.6K17,994Feb 23, 2022Feb 24, 2022View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
12,03733,516Feb 22, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,539$25.01$88.5K29,977Feb 22, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
12,03736,114Feb 22, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
2,022$25.08$50.7K21,479Feb 21, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
6,87523,501Feb 21, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
6,8756,875Feb 21, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
10,09619,592Feb 20, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
10,09620,191Feb 20, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
2,966$25.08$74.4K16,626Feb 20, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
34,88934,889Feb 18, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
139,554139,554Feb 18, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
2,306$25.17$58.0K9,496Feb 18, 2022Feb 23, 2022View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,3750Feb 16, 2022Feb 17, 2022View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
3,37512,871Feb 16, 2022Feb 17, 2022View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
1,069$26.79$28.6K11,802Feb 16, 2022Feb 17, 2022View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
5,647$30.60$172.8K9,496Sep 14, 2021Sep 16, 2021View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
15,14315,143Sep 14, 2021Sep 16, 2021View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
882$24.60$21.7K0Jun 9, 2021Jun 11, 2021View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
1,2500Jun 7, 2021Jun 8, 2021View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
368$23.50$8.6K882Jun 7, 2021Jun 8, 2021View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
1,2501,250Jun 7, 2021Jun 8, 2021View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
28,920$19.72$570.3K0Apr 15, 2021Apr 16, 2021View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
196,484196,484Feb 22, 2021Feb 24, 2021View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
48,15148,151Feb 22, 2021Feb 24, 2021View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
2,022$19.58$39.6K28,920Feb 21, 2021Feb 23, 2021View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
6,87513,750Feb 21, 2021Feb 23, 2021View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
6,87530,942Feb 21, 2021Feb 23, 2021View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,064$19.58$60.0K24,067Feb 20, 2021Feb 23, 2021View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
10,09527,131Feb 20, 2021Feb 23, 2021View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
10,09530,287Feb 20, 2021Feb 23, 2021View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
1,172$19.79$23.2K17,036Feb 16, 2021Feb 18, 2021View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,3753,375Feb 16, 2021Feb 18, 2021View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
3,37518,208Feb 16, 2021Feb 18, 2021View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
1,25015,201Jun 7, 2020Jun 8, 2020View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
368$17.19$6.3K14,833Jun 7, 2020Jun 8, 2020View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
1,2501,250Jun 7, 2020Jun 8, 2020View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
6,87599,825Feb 21, 2020Feb 24, 2020View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
2,004$20.24$40.6K13,951Feb 21, 2020Feb 24, 2020View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
6,87515,955Feb 21, 2020Jan 15, 2021View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
6,87520,625Feb 21, 2020Jan 15, 2021View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
6,87515,955Feb 21, 2020Feb 24, 2020View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
168,856168,856Feb 20, 2020Feb 24, 2020View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
40,38240,382Feb 20, 2020Feb 24, 2020View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
3,3756,750Feb 16, 2020Feb 18, 2020View →
ALKS
ALKERMES PLC.
PURCHASE
EVP R&D, Chief Medical Officer
3,37510,252Feb 16, 2020Feb 18, 2020View →
ALKS
ALKERMES PLC.
SALE
EVP R&D, Chief Medical Officer
1,172$17.77$20.8K9,080Feb 16, 2020Feb 18, 2020View →
Other insiders · ALKS
Loading peer insiders…
About this filer
CIK 0001730048
ROLE
EVP R&D, Chief Medical Officer
PRIMARY
ALKS
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001730048DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback